CoinChat AICrypto, AI and digital finance releases

AI & Data · Week of Nov 2, 2026

Docusign buys Suplari, ECARX signs Arm MoU: the week in AI & Data

Research Solutions linked Scite to Copilot, ECARX and Arm and DataMEDS AI signed MOUs, and Clarivate reported Q3 results after its LS&H sale.

· CoinChat AI newsroom

The clearest thread this week was AI being folded into established work platforms. Research Solutions connected its Scite and Article Galaxy products to Microsoft Copilot, and Docusign acquired procurement intelligence company Suplari to add its technology to the Docusign IAM platform and its Iris AI engine. Non-binding memorandums of understanding were another recurring format: ECARX and Arm signed one covering high-performance AI computing platforms, and DataMEDS AI signed one with an unnamed Florida-based HMO to deploy its Health Lives Here app.

Elsewhere, DataMEDS AI also said its subsidiary Corexa Health secured commercial supply for six compounded peptides. Clarivate reported third quarter 2026 results and updated its outlook after divesting its Life Sciences & Healthcare segment. Robo.ai named W Motors founder Ralph R. Debbas as Group President. Fermi co-founder Toby Neugebauer issued a statement on the company's October 30 annual meeting and called for a sale of the company.

  1. Clarivate Plc

    Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation

    Clarivate reported third quarter 2026 total revenues of $567.9 million including its Life Sciences & Healthcare segment, compared with $623.1 million a year earlier, and a net loss of $80.8 million driven by a $62.2 million non-cash goodwill impairment charge. The company completed the LS&H sale on October 6, 2026 for net cash proceeds of $488.4 million and set a full year 2026 revenue outlook for continuing operations of $1.965B to $1.985B.

  2. Toby Neugebauer

    Fermi's Co-Founder and Largest Shareholder, Toby Neugebauer: "Fermi's Shareholders, the Markets and Texas Voters Have Rejected Rick Perry and Fermi's 'We Can Do Whatever We Want' Board"

    Toby Neugebauer, Fermi Inc.'s co-founder and largest shareholder, says only 38.9% of outstanding shares voted to re-elect Rick Perry and that an August 11 bylaw change adopted without a shareholder vote cost Perry his election. Neugebauer is calling on Fermi to put the company up for sale while closing a tenant deal, and says shareholders will not accept a recapitalization that wipes them out.

  3. Research Solutions, Inc.

    Research Solutions Brings Scite & Article Galaxy To Microsoft Copilot

    Research Solutions announced integrations of its Scite and Article Galaxy products with Microsoft Copilot, available now in the Microsoft Marketplace. The company says users at corporate and academic organizations can search scientific literature and check access rights, pricing and reuse rights without leaving Microsoft 365.

  4. Robo.ai Inc.

    Robo.ai Appoints W Motors Founder Ralph R. Debbas as Group President

    Robo.ai appointed W Motors founder Ralph R. Debbas as Group President, effective immediately, with a focus on industrial strategy, international partnerships and coordination across its businesses. The company also reported progress at units including ALIF Holding, which held a groundbreaking for Phase I of its Umm Al Quwain industrial park, and Neurovia AI, which launched its NeuroStream platform.

  5. DataMEDS AI, Inc.

    DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO

    DataMEDS AI signed a non-binding MOU with an unnamed Florida-based HMO to deploy its Health Lives Here app, initially for members taking GLP-1 receptor agonist medications, on a per member per month revenue model. The companies expect definitive agreements in the fourth quarter of 2026 and a rollout in the first quarter of 2027, and the HMO expects between 25,000 and 30,000 members for 2027.

  6. Docusign, Inc.

    Docusign Acquires Suplari to Accelerate AI-Powered Contract Management for Procurement

    Docusign acquired Seattle-based procurement intelligence company Suplari, founded in 2017, for undisclosed terms, and will add its technology to the Docusign IAM platform. Docusign says combining Suplari with its Iris AI engine is intended to help procurement teams identify savings, track supplier obligations, inform renewals and flag risks, with expanded integrations planned for SAP Ariba, Coupa and Oracle.

  7. ECARX Holdings Inc.

    ECARX Signs MoU with Arm to advance next-generation high-performance AI computing across industry applications

    ECARX and Arm signed a non-binding MoU to explore next-generation high performance AI computing platforms for mobility and cross-industry physical-AI applications in China and global markets. The companies cite prior work through SiEngine, whose 7nm SE1000 automotive-grade SoCs have been in mass production since March 2023, with a 5nm SE2000 platform under development.

  8. DataMEDS AI, Inc.

    DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee

    DataMEDS AI said its subsidiary Corexa Health entered an agreement for commercial supply of bulk drug substance and API for six peptides recommended by the FDA's Pharmacy Compounding Advisory Committee, with Corexa Pharmacy intending to begin dispensing in November 2026. The release states the peptides are compounded drugs that are not FDA-approved, and the company plans to use its Health Lives Here app to help collect and report safety data.

This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not CoinChat AI reporting.